These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 23053782

  • 1. Involvement of αvβ3 integrin in gremlin-induced angiogenesis.
    Ravelli C, Mitola S, Corsini M, Presta M.
    Angiogenesis; 2013 Jan; 16(1):235-43. PubMed ID: 23053782
    [Abstract] [Full Text] [Related]

  • 2. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
    Chiodelli P, Mitola S, Ravelli C, Oreste P, Rusnati M, Presta M.
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
    [Abstract] [Full Text] [Related]

  • 3. Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.
    Corsini M, Moroni E, Ravelli C, Andrés G, Grillo E, Ali IH, Brazil DP, Presta M, Mitola S.
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):136-45. PubMed ID: 24233491
    [Abstract] [Full Text] [Related]

  • 4. Substrate-immobilized HIV-1 Tat drives VEGFR2/α(v)β(3)-integrin complex formation and polarization in endothelial cells.
    Urbinati C, Ravelli C, Tanghetti E, Belleri M, Giacopuzzi E, Monti E, Presta M, Rusnati M.
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):e25-34. PubMed ID: 22362758
    [Abstract] [Full Text] [Related]

  • 5. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
    Kinugasa M, Amano H, Satomi-Kobayashi S, Nakayama K, Miyata M, Kubo Y, Nagamatsu Y, Kurogane Y, Kureha F, Yamana S, Hirata K, Miyoshi J, Takai Y, Rikitake Y.
    Circ Res; 2012 Mar 02; 110(5):716-26. PubMed ID: 22282193
    [Abstract] [Full Text] [Related]

  • 6. Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.
    Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, Ballmer-Hofer K, Zammataro L, Presta M.
    Blood; 2010 Nov 04; 116(18):3677-80. PubMed ID: 20660291
    [Abstract] [Full Text] [Related]

  • 7. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin.
    Nam JO, Son HN, Jun E, Cha K, Lee BH, Park RW, Kim IS.
    Mol Cancer Res; 2012 Aug 04; 10(8):1010-20. PubMed ID: 22710795
    [Abstract] [Full Text] [Related]

  • 8. Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2.
    Hall H, Hubbell JA.
    Microvasc Res; 2004 Nov 04; 68(3):169-78. PubMed ID: 15501236
    [Abstract] [Full Text] [Related]

  • 9. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ikeda S, Ushio-Fukai M, Zuo L, Tojo T, Dikalov S, Patrushev NA, Alexander RW.
    Circ Res; 2005 Mar 04; 96(4):467-75. PubMed ID: 15692085
    [Abstract] [Full Text] [Related]

  • 10. Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.
    Grillo E, Ravelli C, Corsini M, Ballmer-Hofer K, Zammataro L, Oreste P, Zoppetti G, Tobia C, Ronca R, Presta M, Mitola S.
    Oncotarget; 2016 Jun 07; 7(23):35353-68. PubMed ID: 27174917
    [Abstract] [Full Text] [Related]

  • 11. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165.
    Traub S, Morgner J, Martino MM, Höning S, Swartz MA, Wickström SA, Hubbell JA, Eming SA.
    Biomaterials; 2013 Aug 07; 34(24):5958-68. PubMed ID: 23683723
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
    Rapraeger AC, Ell BJ, Roy M, Li X, Morrison OR, Thomas GM, Beauvais DM.
    FEBS J; 2013 May 07; 280(10):2194-206. PubMed ID: 23331867
    [Abstract] [Full Text] [Related]

  • 13. Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.
    Papo N, Silverman AP, Lahti JL, Cochran JR.
    Proc Natl Acad Sci U S A; 2011 Aug 23; 108(34):14067-72. PubMed ID: 21825147
    [Abstract] [Full Text] [Related]

  • 14. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.
    Chiodelli P, Rezzola S, Urbinati C, Federici Signori F, Monti E, Ronca R, Presta M, Rusnati M.
    Oncogene; 2017 Nov 23; 36(47):6531-6541. PubMed ID: 28783175
    [Abstract] [Full Text] [Related]

  • 15. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
    Montenegro CF, Salla-Pontes CL, Ribeiro JU, Machado AZ, Ramos RF, Figueiredo CC, Morandi V, Selistre-de-Araujo HS.
    Biochimie; 2012 Aug 23; 94(8):1812-20. PubMed ID: 22561350
    [Abstract] [Full Text] [Related]

  • 16. β3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand.
    Ravelli C, Grillo E, Corsini M, Coltrini D, Presta M, Mitola S.
    Arterioscler Thromb Vasc Biol; 2015 Oct 23; 35(10):2161-71. PubMed ID: 26293466
    [Abstract] [Full Text] [Related]

  • 17. Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activation.
    Maiolo D, Mitola S, Leali D, Oliviero G, Ravelli C, Bugatti A, Depero LE, Presta M, Bergese P.
    J Am Chem Soc; 2012 Sep 05; 134(35):14573-9. PubMed ID: 22860754
    [Abstract] [Full Text] [Related]

  • 18. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.
    Lakshmikanthan S, Sobczak M, Chun C, Henschel A, Dargatz J, Ramchandran R, Chrzanowska-Wodnicka M.
    Blood; 2011 Aug 18; 118(7):2015-26. PubMed ID: 21636859
    [Abstract] [Full Text] [Related]

  • 19. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
    Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM.
    Cancer Res; 2004 Dec 01; 64(23):8643-50. PubMed ID: 15574772
    [Abstract] [Full Text] [Related]

  • 20. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC, Lee CF, Huang WH, Chou TC.
    Biochem Pharmacol; 2013 May 01; 85(9):1278-87. PubMed ID: 23416116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.